Skip to main content
All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for ELEVANCE HEALTH, INC. · Health Benefits Provider

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Indiana · House · Senate · $90,000.00 income · posted Jul 17, 2026

Official filing document

 Bills named in this filing 1
 Lobbying activity 4
Health Issues

Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. Issues related to Surprise Billing.

Medicare/Medicaid

Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. PBM Reform issues. CY 2027 Medicare Advantage Rate Notice. S. 1105 - No UPCODE Act.

Pharmacy

Prescription Drug Pricing.

Taxation/Internal Revenue Code

Issues related to tax-preferred accounts to help lower the cost of insurance.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem